Media & Announcements
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
26th International Scientific Conference on Expert Education Programs.
Polpharma joins the 26th International Scientific Conference on Expert Education Programs (EPE2026), supporting expert-led pharmaceutical education.
Group News
June 1, 2026
Polish RNA Technology Platform
Polpharma opens Poland's only end-to-end RNA medicine development platform in Starogard Gdanski, a PLN 238.7m investment strengthening medicine security.
Science & Innovation
May 20, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Group News
Polpharma API
October 9, 2024
Polpharma's HP API facility is live!
Polpharma opens Poland's first state-of-the-art facility for highly potent active pharmaceutical ingredients, securing Europe's pharma supply chain.
Group News
Polpharma Group
Ziołolek
October 1, 2024
Polpharma acquires Ziołolek
Polpharma acquires Ziołolek to expand into dermatological products, including the Linomag brand, adding ointment and cream capabilities new to its sites.
Group News
Polpharma Group
September 23, 2024
Polpharma and MSN Laboratories Announce Strategic Distribution Partnership
Polpharma and MSN Laboratories form a strategic distribution partnership bringing MSN's hospital, critical care and specialty products to Polish healthcare.
Corporate Social Responsibility
Polpharma Group
September 3, 2024
The companies Grupa NEUCA, Polpharma, Adamed Pharma, Teva, and Zentiva have formed a strategic partnership for the first time to promote ESG development in pharmacies.
Polpharma, NEUCA, Adamed Pharma, Teva and Zentiva partner on the Medicines Back to the Pharmacy campaign, educating patients on safe disposal of medicines.
Corporate Social Responsibility
Polpharma Group
July 8, 2024
Polpharma is a supporting partner of a charity campaign for children affected by road accidents — the Huge Expedition of „Maluch” Cars
Polpharma backs the Huge Expedition of Maluch Cars, a charity rally of 80 Fiat 126p cars from Warsaw to Monte Cassino aiding child road accident victims.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY